Literature DB >> 34181752

Mobile ECMO retrieval of patients during the COVID-19 pandemic.

Eugen Widmeier1, Daniel Duerschmied1,2, Christoph Benk3, Dawid Staudacher1,2, Tobias Wengenmayer1,2, Alexander Supady1,2,4.   

Abstract

During the coronavirus disease 2019 (COVID-19) pandemic concerns have arisen that rationing of life-saving therapies, such as mechanical ventilation or extracorporeal membrane oxygenation (ECMO), could be necessary due to a surge of patients overwhelming available resources and treatment capacities [1]. ECMO support is particularly resource intensive and should therefore be provided in highly specialized centers, operating formally or informally within a so-called "Hub and Spoke" concept [2, 3]. Consequently, patient transfer capacity between hospitals according to the services needed must be provided to make most effective use of available resources [4]. Occasionally, patients requiring ECMO support must be transferred after out-of-center initiation of ECMO by a mobile ECMO retrieval team [5]. While this approach has been successfully established in various ECMO centers before the outbreak of the COVID-19 pandemic, data on the feasibility and the results of out-of-center initiation of ECMO during the pandemic is scarce [6]. This article is protected by copyright. All rights reserved.

Entities:  

Year:  2021        PMID: 34181752     DOI: 10.1111/aor.14030

Source DB:  PubMed          Journal:  Artif Organs        ISSN: 0160-564X            Impact factor:   3.094


  3 in total

1.  Extracorporeal Membrane Oxygenation Transport in the Wake of the Pandemic Is Feasible and Safe.

Authors:  Bindu Akkanti
Journal:  ASAIO J       Date:  2022-02-01       Impact factor: 2.872

2.  Early platelet dysfunction in patients receiving extracorporeal membrane oxygenation is associated with mortality.

Authors:  Patrick Malcolm Siegel; Julia Chalupsky; Christoph B Olivier; István Bojti; Jan-Steffen Pooth; Georg Trummer; Christoph Bode; Philipp Diehl
Journal:  J Thromb Thrombolysis       Date:  2021-09-16       Impact factor: 2.300

3.  [ECMO support during the first two waves of the corona pandemic-a survey of high case volume centers in Germany].

Authors:  Alexander Supady; Guido Michels; Philipp M Lepper; Markus Ferrari; Jens Wippermann; Anton Sabashnikov; Holger Thiele; Marcus Hennersdorf; Tobias Lahmer; Udo Boeken; Jan Gummert; Eike Tigges; Ralf M Muellenbach; Tobias Spangenberg; Tobias Wengenmayer; Dawid L Staudacher
Journal:  Med Klin Intensivmed Notfmed       Date:  2022-09-08       Impact factor: 1.552

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.